Related Experiment Video
Updated: Mar 3, 2026
12:03
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
18.5K
The Renin-Angiotensin System and Cardiovascular Disease
1a Department of Radiology and Medicine, Brigham and Women's Hospital, Boston, MA 02115-6195 USA.
Blood Pressure
|April 21, 2017
Summary
Angiotensin II type 1 receptor blockers offer effective blood pressure control and cardiovascular protection. These agents provide a favorable side effect profile compared to traditional ACE inhibitors, improving patient compliance.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Renin-angiotensin system (RAS) suppression via ACE inhibitors is a standard hypertension treatment.
- Despite current therapies, poor blood pressure control persists, often due to medication side effects and low patient compliance.
- Target-organ damage from hypertension requires effective blood pressure management.
Purpose of the Study:
- To introduce Angiotensin II type 1 (AT1) receptor blockers as a novel antihypertensive therapeutic class.
- To compare the efficacy and side effect profiles of AT1 receptor blockers with ACE inhibitors.
Main Methods:
- Review of existing literature on antihypertensive mechanisms and clinical outcomes.
- Focus on the pharmacological action of AT1 receptor blockers, such as candesartan.
- Comparison of side effect profiles, specifically cough and angioneurotic edema.
Main Results:
- AT1 receptor blockers effectively lower blood pressure, demonstrating pronounced antihypertensive efficacy.
- AT1 receptor blockers do not cause the cough and angioneurotic edema associated with ACE inhibitors.
- Targeting the AT1 receptor addresses the final common pathway for angiotensin II's negative cardiovascular effects.
Conclusions:
- AT1 receptor blockers represent a significant advancement in managing hypertension and cardiovascular risk.
- Their favorable side effect profile may improve patient compliance and long-term treatment adherence.
- These agents offer a valuable alternative for patients with poor tolerance to ACE inhibitors.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
01:29Hypertension II: Pathophysiology
1.2K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
01:33Hormonal Regulation
36.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.9K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.9K